Oncology Views & Analysis | pharmaphorum

Tuesday 14 July 2026

Views & Analysis

Oncology

ESMO 2024 EVERSANA, Ann Marie Robertson, Vanitha Sankaran, Gurdip Daffu, Barry Vucsko,

Oncology today: EVERSANA and pharmaphorum at ESMO 2024

The ESMO congress always disseminates the latest results of cancer research, a vibrant gathering and sharing of the latest data, communicating the next promising steps in oncological scient

Oncology

ESMO 2024 EVERSANA, Ann Marie Robertson, Vanitha Sankaran, Gurdip Daffu, Barry Vucsko

EVERSANA and pharmaphorum in conversation: ESMO 2024

The ESMO congress always disseminates the latest results of cancer research, a vibrant gathering and sharing of the latest data, communicating the next promising steps in oncological scient

Oncology

Sven Schaffer and Nicole Raleigh interview at ESMO

ESMO 2024 - Sven Schaffer

The European Society for Medical Oncology (ESMO) 2024 meeting was a well-attended affair at the sprawling Fira Gran Via centre in Barcelona.

Oncology

Barcelona and trees with ESMO theme

ESMO 2024 – Today’s oncological roots are branching

What could a tree possibly reveal about the European Society for Medical Oncology (ESMO)?

Oncology

cancer cell growth

CDK9 inhibitors: Disrupting cancer cell growth and the treat...

We have made significant strides in cancer treatment in the last decade and a half.

Oncology

Video interview with Matteo Levisetti

ASCO 2024 - Matteo Levisetti

ASCO 2024 marked the 10th anniversary of checkpoint inhibitors, which powerfully changed the nature of cancer immunotherapy.